Viewing Study NCT03475004


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2026-03-30 @ 3:27 PM
Study NCT ID: NCT03475004
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2018-03-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer
Sponsor: University of Colorado, Denver
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pembrolizumab View
None Binimetinib View
None Bevacizumab View
None Combination Therapy View